Samuel Waxman Cancer Research Foundation

Analysis

Samuel Waxman Cancer Research Foundation is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in June 1983, 43 years ago. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending June 2023, Samuel Waxman Cancer Research Foundation reported income of $4.0m and spending of $4.0m, spending 100% of its income. Across the 5 years on record, from June 2019 to June 2023, income fell from $4.1m to $4.0m (-1.7%), an average of -0.4% a year. The sharpest change came in the year to June 2022, when income rose by 87%. Over the whole period it spent 82% of the income it received.

Among 72,936 United States charities whose main cause is other charitable purposes and that reported income, Samuel Waxman Cancer Research Foundation sits at the 90th percentile: it is larger than about 90% of them. Against every charity in United States with reported income it ranks in the 91st percentile, and in the 88th percentile within NY. Charities of a similar size with the same main cause include Los Angeles Chapter National Tooling & Machine Assn Training CE ($4.0m), Arc of New Jersey Inc ($4.0m) and Hope Partners International ($4.0m).

On its Form 990 for the period ending June 2023, revenue came from contributions and grants 97% of the total. Compensation of current officers, directors and key employees was $834k (21% of expenses). Other salaries and wages came to $295k. It paid $100k in professional fundraising fees. At year end it held assets of $6.2m against liabilities of $310k, net assets of $5.9m. It reported 5 employees.